mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.2 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0005 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0009 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.008 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.08 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.1 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
0.072 |
0.03 |